U-Blot® Research Grade DetumomabCat. No. WA2680$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade DetumomabCat. No. WA2680
U-Blot® Research Grade DerlotuximabCat. No. WA2679
U-Blot® Research Grade DepemokimabCat. No. WA2678
U-Blot® Research Grade DepatuxizumabCat. No. WA2677
U-Blot® Research Grade denrakibartCat. No. WA2676
U-Blot® Research Grade DenosumabCat. No. WA2675
U-Blot® Research Grade DenintuzumabCat. No. WA2674
U-Blot® Research Grade DenikitugCat. No. WA2673
U-Blot® Research Grade DenecimigCat. No. WA2672
U-Blot® Research Grade DemupitamabCat. No. WA2671
U-Blot® Research Grade DemcizumabCat. No. WA2670
U-Blot® Research Grade DelpacibartCat. No. WA2669